Etoposide induces chimeric Mll gene fusions
- 3 November 2003
- journal article
- Published by Wiley in The FASEB Journal
- Vol. 18 (1) , 173-175
- https://doi.org/10.1096/fj.03-0638fje
Abstract
SPECIFIC AIMOur aim was to determine if we could detect the formation of chimeric Mll gene fusions in intact mammalian cells following etoposide treatment, to characterize any such fusion partners, and to determine whether such fusions were detectable after chemotherapy whose mechanism does not include topoisomerase II inhibition.PRINCIPAL FINDINGS1. Etoposide causes formation of Mll fusions whereas vincristine does notIn humans, topoisomerase II inhibitor-induced therapy-related acute leukemia is characterized by chimeric MLL gene fusions, with the vast majority of fusion points occurring in an 8.3-kb breakpoint cluster region (BCR) that encompasses exons 5 through 11. However, MLL partners with over 40 different genes to create leukemogenic gene fusions. The strategy to detect possible etoposide-induced murine Mll chimeric fusions, without bias as to the partner gene, is presented in the overall schematic depicted in Fig. 1⤻ . Amplification of the circularized Mll BCR germline fragment yields a single b...Keywords
Funding Information
- American Lebanese Syrian Associated Charities
This publication has 45 references indexed in Scilit:
- MLL-GAS7 transforms multipotent hematopoietic progenitors and induces mixed lineage leukemias in miceCancer Cell, 2003
- International workshop on the relationship of prior therapy to balanced chromosome aberrations in therapy‐related myelodysplastic syndromes and acute leukemia: Overview reportGenes, Chromosomes and Cancer, 2002
- Chromosomal translocation master genes, mouse models and experimental therapeuticsOncogene, 2001
- Biological and therapeutic aspects of infant leukemiaBlood, 2000
- The Mll-AF9 gene fusion in mice controls myeloproliferation and specifies acute myeloid leukaemogenesisThe EMBO Journal, 1999
- The causes of acute leukemiaCurrent Opinion in Oncology, 1999
- Maternal exposure to potential inhibitors of DNA topoisomerase II and infant leukemia (United States): A report from the Children's Cancer GroupCancer Causes & Control, 1996
- An Mll–AF9 Fusion Gene Made by Homologous Recombination Causes Acute Leukemia in Chimeric Mice: A Method to Create Fusion OncogenesCell, 1996
- In utero rearrangements in the trithorax-related oncogene in infant leukaemiasNature, 1993
- Therapy-related acute myeloid leukemia secondary to inhibitors of topoisomerase II: From the bedside to the target genesAnnals of Oncology, 1992